Literature DB >> 22941792

Approach to the diagnosis and management of common bleeding disorders.

Natalia Rydz1, Paula D James.   

Abstract

Mild mucocutaneous bleeding symptoms are common in the general population. Differentiating normal from pathological bleeding complaints begins with a detailed bleeding history that assesses: the pattern (primary versus secondary hemostasis), the severity, and the onset (congenital versus acquired) of bleeding. Bleeding assessment tools have been developed to aid in determining whether bleeding symptoms are outside of the normal range. Although the clinical pattern of bleeding and family history directs laboratory investigations, von Willebrand disease, the most common and best characterized of the primary hemostatic disorders, is often the first diagnosis to be considered. Clinical management focuses on the particular symptoms experienced by the patient. Medical interventions include replacement of the factor that is deficient or defective, or indirect treatments, such as antifibrinolytics (tranexamic acid), desmopression, and hormone-based therapy (e.g., oral contraceptive pill for menorrhagia). Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2012        PMID: 22941792     DOI: 10.1055/s-0032-1326783

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  6 in total

1.  Hemizygosity for the gene encoding glycoprotein Ibβ is not responsible for macrothrombocytopenia and bleeding in patients with 22q11 deletion syndrome.

Authors:  N M J Zwifelhofer; R S Bercovitz; L A Weik; A Moroi; S LaRose; P J Newman; D K Newman
Journal:  J Thromb Haemost       Date:  2019-01-22       Impact factor: 5.824

Review 2.  Molecular testing for disorders of hemostasis.

Authors:  D Lillicrap
Journal:  Int J Lab Hematol       Date:  2013-06       Impact factor: 2.877

3.  Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause.

Authors:  Johanna Gebhart; Sylvia Kepa; Stefanie Hofer; Silvia Koder; Alexandra Kaider; Alisa S Wolberg; Helmuth Haslacher; Peter Quehenberger; Ernst Eigenbauer; Simon Panzer; Christine Mannhalter; Ingrid Pabinger
Journal:  Ann Hematol       Date:  2016-12-26       Impact factor: 3.673

Review 4.  Why Do Patients Bleed?

Authors:  Jennifer Curnow; Leonardo Pasalic; Emmanuel J Favaloro
Journal:  Surg J (N Y)       Date:  2016-02-24

5.  Thrombin-generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause.

Authors:  Stefanie Hofer; Cihan Ay; Judit Rejtö; Alisa S Wolberg; Helmuth Haslacher; Silvia Koder; Ingrid Pabinger; Johanna Gebhart
Journal:  J Thromb Haemost       Date:  2019-07-15       Impact factor: 5.824

6.  Preoperative screening for bleeding disorders: A comprehensive laboratory assessment of clinical practice.

Authors:  Minka J Vries; Paola E van der Meijden; Gerhardus J Kuiper; Patricia J Nelemans; Rick J Wetzels; René G van Oerle; Marcus D Lancé; Hugo Ten Cate; Yvonne M Henskens
Journal:  Res Pract Thromb Haemost       Date:  2018-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.